Evidence map›Paper›PMID 42032545›Full record

ArticleBMC complementary medicine and therapies2026

Biocatalytic structural diversification of saponins in Zygophyllum decumbens: HR-LC-ESI-TOF-MS/MS profiling and bioactivity modulation.

Nagwan M Gabr, Soad M Abd-ElKhalik, Jaky T Zaki, Lina J M Abdel-Hafez, Alaadin E El-Haddad

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nagwan M GabrPharmacognosy Department, Faculty of Pharmacy, Capital University (formerly Helwan University), Cairo, 11795, Egypt. nagwan.gabr@pharm.helwan.edu.eg.ORCID http://orcid.org/0000-0003-4337-8778
Soad M Abd-ElKhalikPharmacognosy Department, Faculty of Pharmacy, Capital University (formerly Helwan University), Cairo, 11795, Egypt.
Jaky T ZakiPharmacognosy Department, Faculty of Pharmacy, Capital University (formerly Helwan University), Cairo, 11795, Egypt.
Lina J M Abdel-HafezMicrobiology & Immunology Department, Faculty of Pharmacy, October 6 University, Giza, 12585, Egypt.
Alaadin E El-HaddadPharmacognosy Department, Faculty of Pharmacy, October 6 University, Giza, 12585, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundZygophyllum decumbens has been traditionally used in the treatment of gout, fungal infections, diabetes, and rheumatism. These therapeutic effects are primarily attributed to its triterpenoid saponins (TS). The present study explores the biocatalytic transformation of TS to examine structural modifications, identify rare saponins, and evaluate associated changes in biological activity.

methodsTriterpenoid saponins were isolated from shade-dried aerial parts by cold maceration in aqueous alcohol, followed by fractionation and precipitation with acetone, yielding (TS). Three microbial strains, Aspergillus niger, Lactobacillus acidophilus, and Bacillus subtilis, were evaluated for their biocatalytic potential. A. niger demonstrated the highest efficiency and was therefore selected for large-scale biocatalytic transformation, producing a modified saponin fraction (TSM). Both TS and TSM were characterized using high-resolution LC-ESI-TOF-MS/MS. Antifungal activity was assessed by agar diffusion and minimum inhibitory concentration (MIC) assays. Cytotoxic effects were determined using the MTT assay on HepG-2, HT-29, and BNL-CL2 cell lines, while antioxidant activity was evaluated using DPPH and ABTS radical scavenging assays.

resultsA total of thirty-three saponins were tentatively identified, with quinovic acid derivatives predominating. Biocatalysis led to the formation of eight new rare saponins and the loss of two pre-existing ones. Both TS and TSM demonstrated selective antifungal activity, with TSM producing broader inhibition zones and over 70% MIC reduction in most strains, except against Penicillium marneffei. Both fractions exhibited weak cytotoxicity (IC50 > 300 µg/mL) against the tested cell lines. Antioxidant activity declined post-biocatalysis as DPPH values dropped from 40.91 ± 1.87 to 19.90 ± 0.22 µM Trolox equivalents/mg, and ABTS values from 309.66 ± 11.10 to 165.78 ± 4.62 µM Trolox equivalents/mg.

conclusionBiocatalytic treatment with A. niger caused pronounced structural modifications in Z. decumbens saponins, resulting in enhanced selective antifungal activity accompanied by diminished antioxidant capacity. These results highlight microbial biocatalysis as an effective approach for generating structural diversity in plant-derived compounds and modulating their pharmacological properties.

Indexed as

Plant ExtractsSaponinsZygophyllumAntifungal AgentsAntineoplastic AgentsAntioxidantsAspergillus nigerBiocatalysisHep G2 CellsHT29 CellsHumansLiquid Chromatography-Mass SpectrometryMicrobial Sensitivity TestsSpectrometry, Mass, Electrospray IonizationStructure-Activity RelationshipAntifungal AgentsAntineoplastic AgentsAntioxidantsPlant ExtractsSaponinsAntifungalAntioxidantBiocatalysisCytotoxicityTriterpenoid saponinsZygophyllum decumbens

Identifiers

PMID42032545
PMCPMC13110427

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.